OSMOTICA PHARMACEUTICALS PLC's ticker is OSMT and the CUSIP is G6S41R101.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $93 | -76.1% | 1,079,515 | +55.3% | 0.00% | -100.0% |
Q2 2023 | $389 | -51.1% | 694,915 | -0.4% | 0.00% | 0.0% |
Q1 2023 | $795 | -0.7% | 697,415 | -2.5% | 0.00% | 0.0% |
Q4 2022 | $801 | -100.0% | 715,215 | -7.4% | 0.00% | -50.0% |
Q3 2022 | $1,621,000 | +41.8% | 772,007 | -8.1% | 0.00% | +100.0% |
Q2 2022 | $1,143,000 | -31.5% | 840,507 | -14.8% | 0.00% | -50.0% |
Q1 2022 | $1,668,000 | +13.9% | 986,723 | -27.2% | 0.00% | 0.0% |
Q4 2021 | $1,464,000 | -45.9% | 1,355,774 | +47.8% | 0.00% | -33.3% |
Q3 2021 | $2,705,000 | -7.6% | 917,049 | -5.8% | 0.00% | -25.0% |
Q2 2021 | $2,929,000 | -7.0% | 973,102 | +0.7% | 0.00% | 0.0% |
Q1 2021 | $3,151,000 | -25.3% | 966,507 | -5.5% | 0.00% | -20.0% |
Q4 2020 | $4,216,000 | -21.6% | 1,023,207 | +2.9% | 0.01% | 0.0% |
Q3 2020 | $5,379,000 | -16.0% | 994,207 | +4.5% | 0.01% | -16.7% |
Q2 2020 | $6,402,000 | +96.9% | 951,307 | -7.0% | 0.01% | +100.0% |
Q1 2020 | $3,252,000 | -8.8% | 1,022,707 | +100.5% | 0.00% | 0.0% |
Q4 2019 | $3,566,000 | +610.4% | 510,112 | +290.0% | 0.00% | – |
Q3 2019 | $502,000 | +263.8% | 130,812 | +259.3% | 0.00% | – |
Q2 2019 | $138,000 | – | 36,412 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,022,126 | $4,212,000 | 0.89% |
Magnetar Financial LLC | 561,978 | $2,315,000 | 0.03% |
Forefront Analytics, LLC | 18,091 | $72,000 | 0.03% |
Insight Advisors, LLC/ PA | 14,800 | $61,000 | 0.02% |
Engineers Gate Manager LP | 94,378 | $389,000 | 0.02% |
WEDGE CAPITAL MANAGEMENT L L P/NC | 341,700 | $1,408,000 | 0.02% |
Quantitative Systematic Strategies LLC | 25,895 | $107,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 83,867 | $346,000 | 0.01% |
SMITH ASSET MANAGEMENT GROUP LP | 51,890 | $214,000 | 0.01% |
Trexquant Investment LP | 17,467 | $72,000 | 0.01% |